ASSESSING THE SUCCESS OF ENDONASAL SURGICAL MANAGEMENT FOR SUPRAORBITAL CELLS MUCOCELE

Abstract

Background: Treating the mucoceles that originate from the supraorbital ethmoid cells is a challenging task. The lateral
placement of the endoscopic endonasal approach makes it insufficient for sufficient exposure, necessitating the adoption of
prolonged transnasal procedures or external approaches.
Aim: The purpose of this study was to evaluate the success rate of endoscopic procedures performed via the nose using
endoscopes, or endoscopic treatments performed through the nose using transnasal methods or external approaches.
Methods: In order to formulate findings, subjects with mucoceles originating from supraorbital cells that were treated with
an external transpalpebral approach, fat obliteration in the supraorbital cell cavity, and an endonasal extended approach to the
frontal sinus were evaluated.
Results: In supraorbital cells, where inferior and anterior wall erosion was observed in every subject penetrating the orbit,
mucocele was discovered in 8 cases. In two of the cases, there was additional evidence of posterior wall erosion where the
mucocele capsule touched the meningeal. In all eight patients, the illness was cured. However, due to mucocele recurrence, a
novel combination transpalpabral and endonasal technique with supraorbital cell cavity fat obliteration was used in 4
participants.
Conclusion: Treating mucocele in supraorbital cells treated with main or revision surgery has a 100% success rate. Bone
drilling, mucosal excision, and supraorbital cell cavity fat obliteration provide a comprehensive treatment approach
demonstrating significant surgical aggressiveness for mucocele therapy.